Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD) is a progressing disease, with lung but not gut microbiota implicated in its etiology. Here the authors compare the stool from patients with COPD and healthy controls to find specific gut bacteria and metabolites associated with active disease, thereby hi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kate L. Bowerman, Saima Firdous Rehman, Annalicia Vaughan, Nancy Lachner, Kurtis F. Budden, Richard Y. Kim, David L. A. Wood, Shaan L. Gellatly, Shakti D. Shukla, Lisa G. Wood, Ian A. Yang, Peter A. Wark, Philip Hugenholtz, Philip M. Hansbro
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/c37d126ac6bf4df5ae3b32232a535530
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c37d126ac6bf4df5ae3b32232a535530
record_format	dspace
spelling	oai:doaj.org-article:c37d126ac6bf4df5ae3b32232a5355302021-12-02T17:32:58ZDisease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease10.1038/s41467-020-19701-02041-1723https://doaj.org/article/c37d126ac6bf4df5ae3b32232a5355302020-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-19701-0https://doaj.org/toc/2041-1723Chronic obstructive pulmonary disease (COPD) is a progressing disease, with lung but not gut microbiota implicated in its etiology. Here the authors compare the stool from patients with COPD and healthy controls to find specific gut bacteria and metabolites associated with active disease, thereby hinting at a potential role for the gut microbiome in COPD.Kate L. BowermanSaima Firdous RehmanAnnalicia VaughanNancy LachnerKurtis F. BuddenRichard Y. KimDavid L. A. WoodShaan L. GellatlyShakti D. ShuklaLisa G. WoodIan A. YangPeter A. WarkPhilip HugenholtzPhilip M. HansbroNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Kate L. Bowerman Saima Firdous Rehman Annalicia Vaughan Nancy Lachner Kurtis F. Budden Richard Y. Kim David L. A. Wood Shaan L. Gellatly Shakti D. Shukla Lisa G. Wood Ian A. Yang Peter A. Wark Philip Hugenholtz Philip M. Hansbro Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease
description	Chronic obstructive pulmonary disease (COPD) is a progressing disease, with lung but not gut microbiota implicated in its etiology. Here the authors compare the stool from patients with COPD and healthy controls to find specific gut bacteria and metabolites associated with active disease, thereby hinting at a potential role for the gut microbiome in COPD.
format	article
author	Kate L. Bowerman Saima Firdous Rehman Annalicia Vaughan Nancy Lachner Kurtis F. Budden Richard Y. Kim David L. A. Wood Shaan L. Gellatly Shakti D. Shukla Lisa G. Wood Ian A. Yang Peter A. Wark Philip Hugenholtz Philip M. Hansbro
author_facet	Kate L. Bowerman Saima Firdous Rehman Annalicia Vaughan Nancy Lachner Kurtis F. Budden Richard Y. Kim David L. A. Wood Shaan L. Gellatly Shakti D. Shukla Lisa G. Wood Ian A. Yang Peter A. Wark Philip Hugenholtz Philip M. Hansbro
author_sort	Kate L. Bowerman
title	Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease
title_short	Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease
title_full	Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease
title_fullStr	Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease
title_full_unstemmed	Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease
title_sort	disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease
publisher	Nature Portfolio
publishDate	2020
url	https://doaj.org/article/c37d126ac6bf4df5ae3b32232a535530
work_keys_str_mv	AT katelbowerman diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease AT saimafirdousrehman diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease AT annaliciavaughan diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease AT nancylachner diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease AT kurtisfbudden diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease AT richardykim diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease AT davidlawood diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease AT shaanlgellatly diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease AT shaktidshukla diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease AT lisagwood diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease AT ianayang diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease AT peterawark diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease AT philiphugenholtz diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease AT philipmhansbro diseaseassociatedgutmicrobiomeandmetabolomechangesinpatientswithchronicobstructivepulmonarydisease
_version_	1718380147435896832

Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease

Ejemplares similares